These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38105167)
21. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma. Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779 [TBL] [Abstract][Full Text] [Related]
22. Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma. Jayasurya R; Sathyan KM; Lakshminarayanan K; Abraham T; Nalinakumari KR; Abraham EK; Nair MK; Kannan S Mod Pathol; 2005 Aug; 18(8):1056-66. PubMed ID: 15731778 [TBL] [Abstract][Full Text] [Related]
23. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia]. Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721 [TBL] [Abstract][Full Text] [Related]
24. Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study. Wang X; Chen S; Chen X; Zhang C; Liang X J Oral Pathol Med; 2016 Feb; 45(2):83-8. PubMed ID: 26260282 [TBL] [Abstract][Full Text] [Related]
25. [Relationship between human papilloma virus infection and expression of p16 and EGFR in head and neck squamous cell carcinoma and their prognostic significance]. Ma L; Wang D; Wufuer A; Wu R; Zhang S; Wang R Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):23-8. PubMed ID: 24685082 [TBL] [Abstract][Full Text] [Related]
26. Integrated analysis of lncRNA-associated ceRNA network in p16-positive and p16-negative head and neck squamous cell carcinoma. Yang Y; Feng L; Wang R; Ma H; He S; Fang J Medicine (Baltimore); 2022 Aug; 101(33):e26120. PubMed ID: 35984201 [TBL] [Abstract][Full Text] [Related]
27. [Expression and prognostic value of COX- 2, p16(INK4A) and p53 in patients with classical Hodgkin lymphoma]. Shi Y; Gao Z; Liu C; Huang X; Song Y; Ping L; Zhou L; Zhao M; Huang X; Lai Y; Du T; Li M Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):926-32. PubMed ID: 26632465 [TBL] [Abstract][Full Text] [Related]
28. Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma. Barber BR; Biron VL; Klimowicz AC; Puttagunta L; Côté DW; Seikaly H J Otolaryngol Head Neck Surg; 2013 Oct; 42(1):53. PubMed ID: 24401183 [TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma. Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018 [TBL] [Abstract][Full Text] [Related]
30. Expression of p16 and p53 in non-small-cell lung cancer: clinicopathological correlation and potential prognostic impact. Zhou Y; Höti N; Ao M; Zhang Z; Zhu H; Li L; Askin F; Gabrielson E; Zhang H; Li QK Biomark Med; 2019 Jun; 13(9):761-771. PubMed ID: 31157548 [No Abstract] [Full Text] [Related]
31. Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC). Saba NF; Dinasarapu AR; Magliocca KR; Dwivedi B; Seby S; Qin ZS; Patel M; Griffith CC; Wang X; El-Deiry M; Steuer CE; Kowalski J; Shin DM; Zwick ME; Chen ZG PLoS One; 2020; 15(9):e0238497. PubMed ID: 32986729 [TBL] [Abstract][Full Text] [Related]
32. Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma. Ngamphaiboon N; Chureemas T; Siripoon T; Arsa L; Trachu N; Jiarpinitnun C; Pattaranutaporn P; Sirachainan E; Larbcharoensub N Med Oncol; 2019 Jan; 36(2):21. PubMed ID: 30666437 [TBL] [Abstract][Full Text] [Related]
33. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival. Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status. Kikuchi M; Koyasu S; Shinohara S; Usami Y; Imai Y; Hino M; Itoh K; Tona R; Kanazawa Y; Kishimoto I; Harada H; Naito Y Head Neck; 2015 Oct; 37(10):1524-31. PubMed ID: 24890445 [TBL] [Abstract][Full Text] [Related]
35. Identification of AURKA as a Biomarker Associated with Cuproptosis and Ferroptosis in HNSCC. Jia X; Tian J; Fu Y; Wang Y; Yang Y; Zhang M; Yang C; Liu Y Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673957 [TBL] [Abstract][Full Text] [Related]
36. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma. Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442 [TBL] [Abstract][Full Text] [Related]
37. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958 [TBL] [Abstract][Full Text] [Related]
38. Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer. Zhao N; Ang MK; Yin XY; Patel MR; Fritchie K; Thorne L; Muldrew KL; Hayward MC; Sun W; Wilkerson MD; Chera BS; Hackman T; Zanation AM; Grilley-Olson JE; Couch ME; Shockley WW; Weissler MC; Shores CG; Funkhouser WK; Olshan AF; Hayes DN Br J Cancer; 2012 Jul; 107(3):482-90. PubMed ID: 22735904 [TBL] [Abstract][Full Text] [Related]
39. HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis. Yin X; Yang W; Xie J; Wei Z; Tang C; Song C; Wang Y; Cai Y; Xu W; Han W Biomed Res Int; 2019; 2019():5450617. PubMed ID: 31032351 [TBL] [Abstract][Full Text] [Related]
40. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma. Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]